BioCentury
ARTICLE | Clinical News

Hiberix regulatory update

August 24, 2009 7:00 AM UTC

FDA granted accelerated approval to a BLA from GlaxoSmithKline for Hiberix Haemophilus influenzae type B (Hib) vaccine as a booster dose for children ages 15 months to 4 years. The accelerated approva...